Charles River Laboratories
366 hedge funds and large institutions have $6.27B invested in Charles River Laboratories in 2018 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 123 increasing their positions, 132 reducing their positions, and 27 closing their positions.
213% more call options, than puts
Call options by funds: $17M | Put options by funds: $5.43M
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
78% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 27
21% more capital invested
Capital invested by funds: $5.19B → $6.27B (+$1.08B)
5% more funds holding
Funds holding: 348 → 366 (+18)
0.48% more ownership
Funds ownership: 96.64% → 97.11% (+0.48%)
7% less repeat investments, than reductions
Existing positions increased: 123 | Existing positions reduced: 132
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$78.8M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
+$38.4M |
| 3 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
+$37.7M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$31.2M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair Investment Management
Chicago,
Illinois
|
-$188M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$40.5M |
| 3 |
Fidelity International
Hamilton,
Bermuda
|
-$39.2M |
| 4 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$15.4M |
| 5 |
APG Asset Management
Amsterdam,
Netherlands
|
-$12.4M |
CRL Hedge Fund Activity: Q3 2018 in Review
366 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q3 2018, worth a combined $6.27B — up 21% from $5.19B a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new CRL positions and 27 closed out — a net gain of 21 holders — while 123 added to existing stakes and 132 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $78.8M. The largest seller was William Blair Investment Management, exiting entirely with an estimated $188M sold.
- 366 institutional investors held Charles River Laboratories (CRL) as of Q3 2018, up from 348 in Q2 2018.
- Funds reported $6.27B of Charles River Laboratories stock for Q3 2018, up 21% quarter-over-quarter.
- 48 funds opened new Charles River Laboratories positions in Q3 2018 and 27 closed out, a net change of +21 holders.
- The largest Charles River Laboratories buyer in Q3 2018 was Fidelity Investments, an estimated $78.8M added.
- The largest Charles River Laboratories seller in Q3 2018 was William Blair Investment Management, an estimated $188M sold.
Based on aggregated 13F filings for Q3 2018.